Research Article
[Retracted] Clinical Efficacy and Safety of Tumor Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer
Table 1
Patients’ characteristics (
, n (%)).
| | Observation (n = 33) | Experimental (n = 33) | t/x2 | value |
| Age (years) | 27–74 | 26–76 | | | Mean age (years) | 58.62 ± 5.73 | 58.74 ± 5.69 | −0.085 | 0.933 | BMI (kg/m2) | 14.2–33.8 | 14.1–33.6 | | | Mean BMI (kg/m2) | 23.27 ± 4.29 | 23.31 ± 4.34 | −0.038 | 0.97 | Tumor type | | | 0.062 | 0.804 | Primary | 18 | 19 | | | Recurrent | 15 | 14 | | | Pathological type | | | | | Plasma type | 21 | 19 | 0.254 | 0.614 | Mucus type | 4 | 7 | 0.982 | 0.322 | Mixed type | 5 | 7 | 0.407 | 0.523 | Others | 3 | 5 | 0.569 | 0.451 | Lymph node metastasis | | | 0.061 | 0.805 | Yes | 16 | 15 | | | No | 17 | 18 | | |
|
|